Alberta Investment Management Corp (AIMCo)’s Acceleron Pharma XLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-28,800
Closed -$4.97M 1196
2021
Q3
$4.97M Buy
+28,800
New +$3.77M 0.04% 427
2017
Q1
Sell
-49,460
Closed -$1.26M 951
2016
Q4
$1.26M Buy
+49,460
New +$1.57M 0.01% 519

Alberta Investment Management Corp (AIMCo)'s XLRN Position: Q4 2021 in Review

Alberta Investment Management Corp (AIMCo) sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 28,800 shares — an estimated $4.97M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in XLRN in Q4 2016 and held it in 2 quarters. The position peaked at $4.97M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 28,800 Acceleron Pharma shares in Q4 2021, an estimated $4.97M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Acceleron Pharma in Q4 2016 and held it in 2 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Acceleron Pharma position peaked at $4.97M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q4 2021, filed 11 Feb 2022.